It is just like AI rules. Computer rules. Computer rules, yeah, even better way to put it. And I think The US thinks about [AI regulation] much more as the way that you should think about AI regulation. It needs to be use case sector specific, risk based and risk based in nature. So if you think about it, the regulators at FDA who are thinking about AI powered, AI powered medical diagnostics are the ones who should be doing regulations on AI … (31:14–31:25)
CLAIM
Asserts that the US approach to AI regulation is sector-specific and risk-based.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.
